These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 30692085)

  • 1. Environmental risks and non-communicable diseases.
    Prüss-Ustün A; van Deventer E; Mudu P; Campbell-Lendrum D; Vickers C; Ivanov I; Forastiere F; Gumy S; Dora C; Adair-Rohani H; Neira M
    BMJ; 2019 Jan; 364():l265. PubMed ID: 30692085
    [No Abstract]   [Full Text] [Related]  

  • 2. Socioenvironmental factors of communicable and non-communicable diseases.
    Cavalin C; Lescoat A; Macchi O; Revest M; Rosental PA; Jégo P
    Lancet Glob Health; 2017 May; 5(5):e487. PubMed ID: 28395841
    [No Abstract]   [Full Text] [Related]  

  • 3. Pollution and non-communicable disease: time to end the neglect.
    Fuller R; Rahona E; Fisher S; Caravanos J; Webb D; Kass D; Matte T; Landrigan PJ
    Lancet Planet Health; 2018 Mar; 2(3):e96-e98. PubMed ID: 29615229
    [No Abstract]   [Full Text] [Related]  

  • 4. Pollution in living and working environments, climate variability, and their impact on non-communicable disease burden.
    Budnik LT; Casteleyn L; Paschalidou AK; Kassomenos P
    Sci Total Environ; 2019 Apr; 660():593-594. PubMed ID: 30641387
    [No Abstract]   [Full Text] [Related]  

  • 5. Physical Inactivity: The Major Risk Factor for Non-Communicable Diseases.
    Haileamlak A
    Ethiop J Health Sci; 2019 Jan; 29(1):810. PubMed ID: 30700947
    [No Abstract]   [Full Text] [Related]  

  • 6. Global Environmental Change and Noncommunicable Disease Risks.
    Frumkin H; Haines A
    Annu Rev Public Health; 2019 Apr; 40():261-282. PubMed ID: 30633714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cohort Profile: The Fasa Adults Cohort Study (FACS): a prospective study of non-communicable diseases risks.
    Homayounfar R; Farjam M; Bahramali E; Sharafi M; Poustchi H; Malekzadeh R; Mansoori Y; Naghizadeh MM; Vakil MK; Dehghan A
    Int J Epidemiol; 2023 Jun; 52(3):e172-e178. PubMed ID: 36592077
    [No Abstract]   [Full Text] [Related]  

  • 8. Socioeconomic development of cities and risk factors for non-communicable diseases: a comparative study across Brazilian state capitals.
    Borges MC; Santos LP; Zago AM; da Silva BG; da Silva SG; de Mola CL
    J Public Health (Oxf); 2016 Dec; 38(4):653-359. PubMed ID: 28158659
    [No Abstract]   [Full Text] [Related]  

  • 9. Commercial influence in control of non-communicable diseases.
    Whitaker K; Webb D; Linou N
    BMJ; 2018 Jan; 360():k110. PubMed ID: 29330159
    [No Abstract]   [Full Text] [Related]  

  • 10. Strategies for Reducing Non-Communicable Diseases in Africa.
    Olowoyo P; Popoola F; Yaria J; Akinyemi R; Maffia P; Owolabi MO
    Pharmacol Res; 2021 Aug; 170():105736. PubMed ID: 34147659
    [No Abstract]   [Full Text] [Related]  

  • 11. [Developmental Origins of Health and Disease Concept: The environment in the first 1000 days of life and its association with noncommunicable diseases].
    Subcomisión DOHaD – SAP “Origen de la Salud y Enfermedad en el Curso de la Vida” – Sociedad Argentina de Pediatría
    Arch Argent Pediatr; 2020 Aug; 118(4):S118-S129. PubMed ID: 32677802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Editorial: Non-Communicable Diseases: Gender Differences in Therapy.
    Ferroni P
    Curr Med Chem; 2017; 24(24):2559-2560. PubMed ID: 28911300
    [No Abstract]   [Full Text] [Related]  

  • 13. Editorial: Immune-Related Non-Communicable Diseases in Africa.
    Barbouche MR; Eley BS
    Front Immunol; 2021; 12():816257. PubMed ID: 35087535
    [No Abstract]   [Full Text] [Related]  

  • 14. Lower-Income Countries That Face The Most Rapid Shift In Noncommunicable Disease Burden Are Also The Least Prepared.
    Bollyky TJ; Templin T; Cohen M; Dieleman JL
    Health Aff (Millwood); 2017 Nov; 36(11):1866-1875. PubMed ID: 29137514
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Environmental Influences on the Human Microbiome and Implications for Noncommunicable Disease.
    Ahn J; Hayes RB
    Annu Rev Public Health; 2021 Apr; 42():277-292. PubMed ID: 33798404
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How to address non-communicable diseases in urban Africa.
    Hunter-Adams J; Yongsi BN; Dzasi K; Parnell S; Boufford JI; Pieterse E; Oni T
    Lancet Diabetes Endocrinol; 2017 Dec; 5(12):932-934. PubMed ID: 28797749
    [No Abstract]   [Full Text] [Related]  

  • 17. Social determinants and non-communicable diseases: time for integrated action.
    Marmot M; Bell R
    BMJ; 2019 Jan; 364():l251. PubMed ID: 30692093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urbanisation, inequality, and non-communicable disease risk.
    The Lancet Diabetes Endocrinology
    Lancet Diabetes Endocrinol; 2017 May; 5(5):313. PubMed ID: 28395876
    [No Abstract]   [Full Text] [Related]  

  • 19. The significance of non-communicable threats to travellers: time for a sea-change?
    Sanford CA; Flaherty GT
    J Travel Med; 2019 Jan; 26(1):. PubMed ID: 30476161
    [No Abstract]   [Full Text] [Related]  

  • 20. The Double Burden of Communicable and Non-Communicable Diseases.
    Erhabor GE
    West Afr J Med; 2023 Apr; 40(4):353-354. PubMed ID: 37115701
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.